You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

CLINICAL TRIALS PROFILE FOR DIPHEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for DIPHEN

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01158820 ↗ Alternative Sedation During Bronchoscopy Completed Hospira, Inc. Phase 4 2010-06-01 This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗ Alternative Sedation During Bronchoscopy Completed Hospira, now a wholly owned subsidiary of Pfizer Phase 4 2010-06-01 This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01158820 ↗ Alternative Sedation During Bronchoscopy Completed University of Pennsylvania Phase 4 2010-06-01 This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.
NCT01165866 ↗ Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis Completed Hamad Medical Corporation Phase 4 2008-06-01 Is intravenous metoclopramid as effective as intravenous ondansetron in the treatment of persistent vomiting in patients with acute gastroenteritis.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for DIPHEN

Condition Name

Condition Name for DIPHEN
Intervention Trials
Gastroenteritis 1
Sedation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for DIPHEN
Intervention Trials
Vomiting 1
Gastroenteritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for DIPHEN

Trials by Country

Trials by Country for DIPHEN
Location Trials
Qatar 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for DIPHEN
Location Trials
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for DIPHEN

Clinical Trial Phase

Clinical Trial Phase for DIPHEN
Clinical Trial Phase Trials
Phase 4 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for DIPHEN
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DIPHEN

Sponsor Name

Sponsor Name for DIPHEN
Sponsor Trials
Hospira, Inc. 1
Hospira, now a wholly owned subsidiary of Pfizer 1
University of Pennsylvania 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for DIPHEN
Sponsor Trials
Industry 3
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.